🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,79 USD

Máx. histórico

61,25

1784 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-49,73%

Rango 52 semanas

23,62 – 31,06

Variación hoy

+2,63%

Cierre anterior

30,00

Rango de hoy

30,04 – 30,90

Volumen hoy

48.251.619

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,61 (puede no estar actualizado)
Dividend yield
5,73% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 9 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,59%
Fecha de pago Importe por participación
24/07/2026 0,4300 USD
08/05/2026 0,4300 USD
23/01/2026 0,4300 USD
07/11/2025 0,4300 USD
25/07/2025 0,4300 USD
09/05/2025 0,4300 USD
24/01/2025 0,4300 USD
08/11/2024 0,4200 USD
26/07/2024 0,4200 USD
09/05/2024 0,4200 USD
25/01/2024 0,4200 USD
09/11/2023 0,4100 USD
27/07/2023 0,4100 USD
11/05/2023 0,4100 USD
26/01/2023 0,4100 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/12/2015 30,83 31,04 30,83 30,95 +0,18% 0,68% 8.355.690
23/12/2015 30,91 31,06 30,86 30,89 +0,12% 0,64% 22.101.748
22/12/2015 30,95 30,95 30,70 30,85 +0,18% 0,80% 26.882.165
21/12/2015 30,52 30,80 30,37 30,80 +1,47% 1,40% 32.277.064
18/12/2015 30,60 30,79 30,31 30,35 -1,05% 1,55% 70.213.475
17/12/2015 30,89 31,00 30,65 30,67 -0,77% 1,14% 40.396.658
16/12/2015 30,77 31,00 30,35 30,91 +0,99% 2,10% 46.831.328
15/12/2015 30,95 31,14 30,52 30,61 +0,25% 1,99% 49.895.622
14/12/2015 30,35 30,56 30,21 30,53 +0,37% 1,16% 40.355.868
11/12/2015 30,46 30,58 30,33 30,42 -0,93% 0,81% 42.450.061
10/12/2015 30,77 31,04 30,59 30,70 +0,22% 1,48% 55.644.665
09/12/2015 30,76 30,98 30,47 30,64 -0,74% 1,63% 41.694.343
08/12/2015 30,69 31,06 30,64 30,86 -0,40% 1,39% 27.124.058
07/12/2015 31,06 31,20 30,79 30,99 -0,43% 1,31% 22.100.483
04/12/2015 30,83 31,20 30,75 31,12 +1,27% 1,48% 33.320.945
03/12/2015 31,23 31,31 30,70 30,73 -1,55% 1,94% 49.909.640
02/12/2015 31,95 32,10 31,11 31,21 -2,14% 3,09% 33.547.134
01/12/2015 31,31 32,00 31,12 31,90 +2,59% 2,82% 51.963.254
30/11/2015 31,22 31,22 30,86 31,09 -0,06% 1,15% 45.230.091
27/11/2015 31,23 31,31 31,00 31,11 -0,24% 1,00% 16.989.848
25/11/2015 30,70 31,54 30,56 31,19 +2,82% 3,18% 83.669.682
24/11/2015 29,77 30,50 29,62 30,33 +2,04% 2,96% 88.563.404
23/11/2015 29,81 30,07 29,40 29,72 -2,64% 2,23% 131.376.462
20/11/2015 30,91 30,92 30,44 30,53 -0,34% 1,57% 68.087.978
19/11/2015 31,11 31,28 30,31 30,64 -3,06% 3,11% 95.611.186
18/11/2015 31,39 31,72 31,24 31,60 +1,34% 1,51% 37.905.318
17/11/2015 31,50 31,75 31,19 31,19 -0,87% 1,78% 31.295.579
16/11/2015 31,58 31,70 31,17 31,46 -0,33% 1,68% 27.021.503
13/11/2015 31,63 31,95 31,44 31,57 -0,36% 1,62% 19.041.459
12/11/2015 31,89 31,97 31,64 31,68 -1,04% 1,04% 18.972.316